HOOK(Delisted)
HOOKIPA Pharma·NASDAQ
--
--(--)
HOOKIPA Pharma (HOOK) Financial Statements
HOOKIPA Pharma (HOOK) Cash Flow Statement
During Q1 2024, HOOKIPA Pharma (HOOK) generated -24.16M in cash flow from operating activities, -116.00K from investing activities, and -135.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2018 | Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q1,2024 | TTM |
|---|
Start Date | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2024 | -- |
End Date | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -4.97M -- | -12.06M -142.48% | -7.13M +40.88% | -14.40M -101.98% | 1.73M +112.04% | -2.85M -264.34% | -24.16M -748.17% | -- -- |
Depreciation and Amortization | 140.00K -- | 297.00K +112.14% | 903.00K +204.04% | 1.10M +22.15% | 1.08M -2.27% | 921.00K -14.56% | 640.00K -30.51% | -- -- |
Change in Working Capital | -624.00K -- | 1.42M +328.21% | 4.42M +210.18% | -69.00K -101.56% | 16.93M +24633.33% | 14.49M -14.41% | -36.50M -351.96% | -- -- |
Net Cash Flows from Investing Activities | -262.00K -- | -400.00K -52.67% | -199.00K +50.25% | -330.00K -65.83% | -1.83M -453.94% | -274.00K +85.01% | -116.00K +57.66% | -- -- |
Purchase of PPE and Intangible Assets | 262.00K -- | 400.00K +52.67% | 199.00K -50.25% | 330.00K +65.83% | 1.83M +453.94% | 274.00K -85.01% | 116.00K -57.66% | -- -- |
Net Cash Flows from Financing Activities | 6.88M -- | 35.16M +411.08% | -1.28M -103.65% | 101.00K +107.87% | 75.29M +74447.52% | -735.00K -100.98% | -135.00K +81.63% | -- -- |
Change in Capital Stock | 6.44M -- | 37.27M +478.88% | 8.00K -99.98% | 125.00K +1462.50% | 75.31M +60150.40% | 1.00K -100.00% | -- -- | -- -- |
Increase in Capital Stock | 6.44M -- | 37.27M +478.88% | 8.00K -99.98% | 125.00K +1462.50% | 75.31M +60150.40% | 1.00K -100.00% | -- -- | -- -- |
Effect of Foreign Exchange Rate Changes | 1.75M -- | -773.00K -144.17% | -87.00K +88.75% | -406.00K -366.67% | -307.00K +24.38% | 434.00K +241.37% | -159.00K -136.64% | -- -- |
Net Increase in Cash and Cash Equivalents | 3.40M -- | 21.93M +545.89% | -8.70M -139.67% | -15.03M -72.82% | 74.89M +598.21% | -3.42M -104.57% | -24.57M -617.67% | -- -- |
Cash and Cash Equivalents at Beginning of Period | 61.36M -- | 48.58M -20.83% | 113.58M +133.79% | 143.18M +26.06% | 66.91M -53.27% | 113.44M +69.54% | 117.52M +3.59% | -- -- |
Cash and Cash Equivalents at End of Period | 64.76M -- | 70.51M +8.88% | 104.88M +48.74% | 128.15M +22.19% | 141.80M +10.66% | 110.02M -22.41% | 92.95M -15.51% | -- -- |
You can ask Aime
No Data
